The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.
about
Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson's diseaseModeling Parkinson's disease in the common marmoset (Callithrix jacchus): overview of models, methods, and animal careMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceGenetically engineered mouse models of Parkinson's diseaseMitochondrial iron-sulfur cluster dysfunction in neurodegenerative diseasePioglitazone ameliorates the phenotype of a novel Parkinson's disease mouse model by reducing neuroinflammationQuantification of mitochondrial morphology in neurites of dopaminergic neurons using multiple parametersSelective degeneration of dopaminergic neurons by MPP(+) and its rescue by D2 autoreceptors in Drosophila primary cultureEnergy failure: does it contribute to neurodegeneration?Resistance to MPTP-neurotoxicity in α-synuclein knockout mice is complemented by human α-synuclein and associated with increased β-synuclein and Akt activationCHOP/GADD153 is a mediator of apoptotic death in substantia nigra dopamine neurons in an in vivo neurotoxin model of parkinsonismAltered dopamine signaling and MPTP resistance in mice lacking the Parkinson's disease-associated GPR37/parkin-associated endothelin-like receptorA monoclonal antibody-GDNF fusion protein is not neuroprotective and is associated with proliferative pancreatic lesions in parkinsonian monkeysA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseIdentification of Neurexophilin 3 as a Novel Supportive Factor for Survival of Induced Pluripotent Stem Cell-Derived Dopaminergic ProgenitorsMemory, mood, dopamine, and serotonin in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.MPTP and DSP-4 susceptibility of substantia nigra and locus coeruleus catecholaminergic neurons in mice is independent of parkin activity.Murine motor and behavior functional evaluations for acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) intoxication.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Nitrated alpha-synuclein immunity accelerates degeneration of nigral dopaminergic neurons.Involvment of cytosolic and mitochondrial GSK-3beta in mitochondrial dysfunction and neuronal cell death of MPTP/MPP-treated neuronsSex differences in motor behavior in the MPTP mouse model of Parkinson's disease.Toxin-induced models of Parkinson's disease.Gene-environment interaction models to unmask susceptibility mechanisms in Parkinson's disease.An in vivo microdialysis study of FLZ penetration through the blood-brain barrier in normal and 6-hydroxydopamine induced Parkinson's disease model rats.5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.A neuroprotective role for angiogenin in models of Parkinson's diseaseNeuroprotective effects of cuscutae semen in a mouse model of Parkinson's disease.Modeling a sensitization stage and a precipitation stage for Parkinson's disease using prenatal and postnatal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administrationPET imaging a MPTP-induced mouse model of Parkinson's disease using the fluoropropyl-dihydrotetrabenazine analog [18F]-DTBZ (AV-133)A single intramuscular injection of rAAV-mediated mutant erythropoietin protects against MPTP-induced parkinsonism.Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.Animal models of Parkinson's disease.A novel transferrin/TfR2-mediated mitochondrial iron transport system is disrupted in Parkinson's disease.Nonhuman primate models of Parkinson's disease.Preclinical assessment of stem cell therapies for neurological diseases.Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration.NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.Alterations in neuronal activity in basal ganglia-thalamocortical circuits in the parkinsonian state.α-Synuclein, leucine-rich repeat kinase-2, and manganese in the pathogenesis of Parkinson disease
P2860
Q24609725-AE1238FE-B3D8-4EB4-9B01-D3D495B32A87Q26772285-01CE38A7-8A00-4718-A52D-4CB7F819C3BFQ26773064-161CC64C-2FF1-420A-9F25-1908E3A9E779Q26852964-4F15F411-1927-44B6-95F6-1B0234B0649DQ27015737-E035EC65-E8BD-4524-A073-B8314303EB37Q27301100-B2DB0880-D9AB-4EF0-8F4D-E6DC1187AC77Q28272173-6972358E-3FB3-4281-BDFF-52F9C6E5AA5AQ28286470-3C81791A-C945-475B-80C4-E6BBF47DE99CQ28389950-B5A2FFAF-CE16-4EB3-97EF-1415F55C2BC5Q28477043-CCC62296-BD19-4218-B5AA-86D3AE4A2AEFQ28579022-E121369E-A6EA-4C61-9C7E-8C893A3CE204Q28588013-734C803F-5EA5-4B48-994B-3658E05F56B3Q28728201-196DB231-B7E9-4412-A2E2-B69ACFB23945Q28830946-6D7DA14A-87DD-484C-8303-BE9A37AA6D6AQ30377980-89DDD3C5-6225-4C59-9912-93739E9C8F34Q30470435-D5E652DE-4BAC-4FFE-BEE3-57571FFF0A18Q30502685-B5859E76-507B-4D49-9B7D-D60D49ED2AA8Q30519556-79E22A38-DE4D-4715-8C23-37DD0CB7BEF7Q31109638-14A34D91-7ADB-4BDA-AB73-0CB66E614381Q33312931-E6ADA1C5-7A1E-41AC-8E63-80672EB50CE2Q33442821-2B9D1808-0819-482C-B794-85D6856853F9Q33835301-5FE09C4F-31EC-4276-A339-EF410CB260EDQ33844749-8EA83FB8-590E-4AF5-B759-6F24217DA9C6Q33872463-CE071EB6-4C35-4041-87F7-C86604D627AEQ33876743-ED138B89-D649-49D4-8224-BD12E24E4319Q33886545-EB4EBE14-83BE-4D49-8C12-EFFEB5D82A73Q34024770-6A6341D0-C148-492A-80A8-64220DD8AC63Q34032558-6CED1159-3BFB-499A-96BA-3551259D5A40Q34037199-569F8DBF-FF20-4F83-9F53-69ED7A57268DQ34314094-D83BB8ED-6F24-4A66-982C-D457BDE68B29Q34314213-F95A450E-45A5-4C07-B2DA-F8081ECD6319Q34394747-D9BA76D5-FB0E-439C-9813-BE9ECB1DE920Q34596189-FA151A71-27A1-43AA-A130-D681CD942D33Q34658144-6FB28BB1-3728-40CD-B34F-514550EB1112Q34665820-B716839E-89C6-49D2-B9D6-70085D217774Q34786764-CD7D14D2-D1E5-4FD3-9DF8-E6C43E73EE70Q34983386-83FE9355-AA96-442D-9E03-733E1966C370Q35022998-EB009244-F6FC-41F3-929B-867B0B10CBA6Q35053448-6EE63802-B2D4-4798-A2F8-4CB55CD2812CQ35100189-E819B3A7-2E4B-49D9-8CD7-7CFD0DE92BF9
P2860
The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety.
description
2001 nî lūn-bûn
@nan
2001 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի մարտին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@ast
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@en
type
label
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@ast
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@en
prefLabel
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@ast
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@en
P2093
P2860
P1476
The parkinsonian toxin 1-methy ...... iew of its utility and safety.
@en
P2093
P2860
P304
P356
10.1046/J.1471-4159.2001.00183.X
P407
P577
2001-03-01T00:00:00Z